2021-01-11,EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 Net Product Revenues
2021-01-05,Will Walgreens Boots' (WBA) Retail Arm Be Dull in Q1 Earnings?
2021-01-05,"What You Need To Know About EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Investor Composition"
2021-01-03,EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
2020-12-18,EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation
2020-12-08,EyePoint Pharmaceuticals Announces 1-for-10 Reverse Stock Split
2020-12-03,"EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a Potential Six-month Treatment of Wet Age-related Macular Degeneration"
2020-11-25,"Where Do Hedge Funds Stand On EyePoint Pharmaceuticals, Inc. (EYPT)?"
2020-11-19,EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4
2020-11-16,EyePoint Pharmaceuticals Presents Positive Data of YUTIQ® and DEXYCU® in Four Poster Sessions at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
2020-11-10,EyePoint Pharmaceuticals Announces Presentations at the Upcoming American Academy of Ophthalmology 2020 Virtual Annual Meeting
2020-11-05,"EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Tops Revenue Estimates"
2020-11-05,EyePoint Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Corporate Developments
2020-10-29,EyePoint Pharmaceuticals (EYPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-10-29,EyePoint Pharmaceuticals Announces Third Quarter 2020 Financial Results Release Date and Conference Call Information
2020-10-08,EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility Modifying 2020 and 2021 Revenue Covenants
2020-10-07,EyePoint Pharmaceuticals Announces Preliminary Net Product Revenue for Third Quarter 2020
2020-09-30,"Who Has Been Buying EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares?"
2020-09-10,EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
2020-08-26,Insider Buys EyePoint Pharmaceuticals's Shares
2020-08-24,EyePoint Pharmaceuticals Secures New Purchase and Marketing Agreement with Vantage Outsourcing for DEXYCU®
2020-08-20,EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License Agreements
2020-08-05,"EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-05,EyePoint Pharmaceuticals: Q4 Earnings Insights
2020-08-05,EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments
2020-08-04,EyePoint Pharmaceuticals and Harrow Healths ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®
2020-07-29,EyePoint Pharmaceuticals Announces Second Quarter 2020 Financial Results Release Date and Conference Call Information
2020-07-27,EyePoint Pharmaceuticals Presents Data Supporting YUTIQ® at the American Society of Retina Specialists (ASRS) Virtual Annual Meeting
2020-07-13,"EyePoint Pharmaceuticals Expands Executive Leadership Team with the Appointment of Jay S. Duker, M.D., as Chief Strategic Scientific Officer"
2020-07-02,"EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Profit Outlook"
2020-06-24,Edited Transcript of EYPT.OQ earnings conference call or presentation 6-May-20 12:30pm GMT
2020-06-18,EyePoint Pharmaceuticals (EYPT) Surges: Stock Moves 7.4% Higher
2020-05-27,"Should You Buy EyePoint Pharmaceuticals, Inc. (EYPT)?"
2020-05-26,EyePoint Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
2020-05-18,EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting
2020-05-06,"EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates"
2020-05-06,EyePoint Pharmaceuticals: Q3 Earnings Insights
2020-05-06,EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments
2020-04-29,EyePoint Pharmaceuticals Announces First Quarter 2020 Financial Results Release Date and Conference Call Information
2020-04-08,Sage slashes 53% of staff as hospitals cut inpatient stays
2020-04-01,EyePoint Pharmaceuticals Provides COVID-19 Pandemic Business Operations Update
2020-03-31,3 Penny Stocks With Triple-Digit Upside Potential
2020-03-23,Edited Transcript of EYPT earnings conference call or presentation 5-Mar-20 1:30pm GMT
2020-03-05,"EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-05,EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress
2020-03-02,EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQ®
2020-02-27,EyePoint Pharmaceuticals Announces Fourth Quarter and Full-Year 2019 Financial Results Release Date and Conference Call Information
2020-02-21,EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2020-02-21,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion"
2020-02-20,EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
2020-02-18,EyePoint Pharmaceuticals and Vision Center Network of America Sign Purchase Agreement for DEXYCU®
2020-02-04,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares"
2020-02-03,"EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion"
2020-01-30,Will EyePoint Continue to Surge Higher?
2020-01-27,"EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCU® for Post-operative Inflammation in Mainland China, Hong Kong, Macau and Taiwan"
2020-01-23,EyePoint Pharmaceuticals Announces Preliminary Fourth Quarter and Full-Year 2019 Revenues
2019-12-22,"EyePoint Pharmaceuticals, Inc. (EYPT): Hedge Fund Sentiment Unchanged"
2019-12-04,EyePoint Pharmaceuticals Announces New Agreement for Expanded Access of DEXYCU® Within One of the Largest Integrated Delivery Systems in the U.S.
2019-11-25,Edited Transcript of EYPT earnings conference call or presentation 7-Nov-19 1:30pm GMT
2019-11-19,EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility
2019-11-14,EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development
2019-11-07,"EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates"
2019-11-07,EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress
2019-11-04,EyePoint Pharmaceuticals Announces Addition of DEXYCU® and YUTIQ® to Department of Veteran Affairs Federal Supply Schedule
2019-11-01,EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®
2019-10-31,Will EyePoint Pharmaceuticals (EYPT) Report Negative Earnings Next Week? What You Should Know
2019-10-24,EyePoint Pharmaceuticals Announces Third Quarter 2019 Financial Results Release Date and Conference Call Information
2019-10-02,EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect
2019-09-27,EyePoint Pharmaceuticals Announces YUTIQ® Presentations at the American Academy of Ophthalmology 2019 Annual Meeting
2019-09-26,EyePoint Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
2019-09-09,EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 52nd Annual Retina Society Scientific Meeting
2019-09-06,Edited Transcript of EYPT earnings conference call or presentation 7-Aug-19 12:30pm GMT
2019-08-23,Keep Your Eye on These 4 Healthcare Stocks
2019-08-07,"EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-07,EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
2019-07-31,EyePoint Pharmaceuticals (EYPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2019-07-31,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster"
2019-07-30,EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
2019-07-25,EyePoint Pharmaceuticals Announces Early Assignment of Permanent and Specific J-Code J7314 for YUTIQ® by the Center for Medicare and Medicaid Services (CMS)
2019-07-24,EyePoint Pharmaceuticals Announces Second Quarter 2019 Financial Results Release Date and Conference Call Information
2019-07-23,EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
2019-07-15,"EyePoint Pharmaceuticals Appoints Wendy DiCicco, CPA, to Board of Directors"
2019-07-08,"EyePoint Pharmaceuticals, Inc. - U.S. Commercialization of DEXYCU® (dexamethasone intraocular suspension) 9%"
2019-07-01,EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes
2019-06-29,"Hedge Funds Have Never Been This Bullish On EyePoint Pharmaceuticals, Inc. (EYPT)"
2019-06-13,EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-06-10,EyePoint Pharmaceuticals Strengthens Executive Leadership Team with Key Hires
2019-05-17,Edited Transcript of EYPT earnings conference call or presentation 8-May-19 12:30pm GMT
2019-05-15,EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
2019-05-08,"EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue Estimates"
2019-05-08,EyePoint Pharmaceuticals: 1Q Earnings Snapshot
2019-05-08,EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
2019-05-01,Will EyePoint Pharmaceuticals (EYPT) Report Negative Earnings Next Week? What You Should Know
2019-05-01,EyePoint Pharmaceuticals Presents Positive YUTIQ 36-month Follow-up Phase 3 Data at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
2019-04-23,EyePoint Pharmaceuticals Announces First Quarter 2019 Financial Results Release Date and Conference Call Information
2019-04-16,EyePoint Pharmaceuticals to Present at Upcoming Medical Conferences
2019-04-02,EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
2019-03-28,Here's Why EyePoint Pharmaceuticals Saw Its Share Price Drop Today
2019-03-28,EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2019-03-27,EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
